Abbott Laboratories (ABT) Current Taxes (2009 - 2026)

Abbott Laboratories (ABT) has 18 years of Current Taxes data on file, last reported at $598.0 million in Q1 2026.

• For the quarter ending Q1 2026, Current Taxes rose 23.3% year-over-year to $598.0 million; the trailing twelve-month figure through Mar 2026 stood at $598.0 million (up 23.3% YoY), and the FY2025 full-year result was $569.0 million, down 4.21% from the prior year.
• Current Taxes rose to $598.0 million in Q1 2026, from $569.0 million in the prior quarter.
• In the past five years, Current Taxes ranged from a high of $713.0 million in Q3 2024 to a low of $273.0 million in Q2 2023.
• A 5-year average of $460.5 million and a median of $469.0 million in 2025 frame the typical range for Current Taxes.
• Across the five-year window, Current Taxes soared 124.21% in 2024 and tumbled 35.11% in 2025, its largest moves.
• Tracing ABT's Current Taxes over 5 years: stood at $343.0 million in 2022, then jumped by 43.44% to $492.0 million in 2023, then rose by 20.73% to $594.0 million in 2024, then declined by 4.21% to $569.0 million in 2025, then grew by 5.1% to $598.0 million in 2026.
• Business Quant data shows ABT's Current Taxes at $598.0 million in Q1 2026, $569.0 million in Q4 2025, and $469.0 million in Q3 2025.